0001209191-15-079673.txt : 20151112
0001209191-15-079673.hdr.sgml : 20151112
20151112160905
ACCESSION NUMBER: 0001209191-15-079673
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20151104
FILED AS OF DATE: 20151112
DATE AS OF CHANGE: 20151112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRENNAN DANIEL
CENTRAL INDEX KEY: 0001657999
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 151224887
MAIL ADDRESS:
STREET 1: C/O INSYS THERAPEUTICS, INC
STREET 2: 1333 SOUTH SPECTRUM BLVD, SUITE 100
CITY: CHANDLER
STATE: AZ
ZIP: 85286
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-11-04
0
0001516479
Insys Therapeutics, Inc.
INSY
0001657999
BRENNAN DANIEL
C/O INSYS THERAPEUTICS, INC.
1333 SO. SPECTRUM BLVD. # 100
CHANDLER
AZ
85286
0
1
0
0
Exec VP & Chf Operations Off.
Common Stock
5782
D
Stock Option (right to buy)
28.83
2025-11-02
Common Stock
250000
D
The option vests in 48 equal monthly installments and will be fully vested and exercisable on November 3, 2019.
/s/ Darryl Baker, Attorney-in-Fact
2015-11-11
EX-24.3_614221
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
Darryl S. Baker of Insys Therapeutics, Inc. (the "Company") as the undersigned's
true and lawful attorney-in fact and agent to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of the Company, Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact
shall no longer be employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 11th day of November, 2015.
/s/ Daniel Brennan
Daniel Brennan, Executive V.P. & Chief Operations Officer